SCHEMBL164425

SCHEMBL164425

CN(C)C(=O)c1cccc(C(=O)NCc2ccccn2)c1

nearest known ligand 0.61

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.61
CYP3A4 P08684 1/20 0.61
KDM4E B2RXH2 2/20 0.59
KMT2A Q03164 6/20 0.57
MEN1 O00255 5/20 0.57
NPC1 O15118 3/20 0.56
RAB9A P51151 3/20 0.56
POLB P06746 2/20 0.56
LMNA P02545 2/20 0.56
MAPK14 Q16539 1/20 0.53
SMN1; SMN2 Q16637 3/20 0.53
TSHR P16473 1/20 0.53
HPGD P15428 1/20 0.53
HSD17B10 Q99714 1/20 0.53
NAMPT P43490 1/20 0.53
ALDH1A1 P00352 3/20 0.53
CA2 P00918 1/20 0.52
HTT P42858 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13702299 0.85 CYP1A2 (0.65) CYP1A2CYP3A4KDM4EKMT2AMEN1
SCHEMBL166939 0.84 CYP1A2 (0.67) CYP1A2CYP3A4KDM4EKMT2AMEN1
SCHEMBL166100 0.83 MEN1 (0.64) CYP1A2CYP3A4KDM4EKMT2AMEN1
SCHEMBL11722616 0.83 KDM4E (0.67) CYP1A2CYP3A4KDM4EKMT2AMEN1
SCHEMBL3644078 0.83 CYP1A2 (0.65) CYP1A2CYP3A4KDM4EKMT2AMEN1
SCHEMBL13701753 0.82 CYP1A2 (0.61) CYP1A2CYP3A4KDM4EKMT2AMEN1
SCHEMBL1573212 0.81 CYP1A2 (0.67) CYP1A2CYP3A4KDM4EKMT2AMEN1
SCHEMBL166484 0.80 LMNA (0.82) CYP1A2CYP3A4KDM4EKMT2AMEN1
SCHEMBL31396771 0.80 CYP1A2 (0.65) CYP1A2CYP3A4KDM4EKMT2AMEN1
SCHEMBL29818105 0.80 CYP1A2 (0.65) CYP1A2CYP3A4KDM4EKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2611441-A1 BACE INHIBITORS FOR USE IN THE TREATMENT OF DIABETES F.HOFFMANN-LA ROCHE AG (CH) 2013-07-10 EP disclosed
WO-2012028563-A1 BACE INHIBITORS FOR USE IN THE TREATMENT OF DIABETES F. HOFFMANN-LA ROCHE AG (CH) 2012-03-08 WO disclosed